Clinical Trials Browser

Phase 2 × Lymphoma × Dasatinib × Clear all

NCT00364286 2026-01-20

Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)

Phase 2 Completed

17 enrolled 5 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

NCT04439305 2020-07-20

Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X)

Phase 2 Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Hematologic Neoplasms